Development of green micellar HPLC–DAD method for simultaneous determination of some sulbactam combinations used in COVID-19 regimen

Table 3 Results obtained for analysis of different dosage forms containing the drugs under study

Dosage form	Composition	Labeled content (per table)	Assayed content	Found% ± RSD
Unictam® Vial	AMP	1000 mg AMP + 500 mg SLB	150 mg AMP + 75 mg SLB	102.25 ± 0.22
	SLB		100 mg AMP + 50 mg SLB	101.68 ± 0.18
			50 mg AMP + 25 mg SLB	100.28 ± 0.37
Sulbacef® Vial	CFP	1000 mg CFP + 500 mg SLB	150 mg CFP + 75 mg SLB	100.72 ± 0.07
	SLB		100 mg CFP + 50 mg SLB	100.96 ± 1.88
			50 mg CFP + 25 mg SLB	100.16 ± 0.14
Suprax® Capsules			150 mg	100.29 ± 0.23
	CFX	200 mg	100 mg	100.93 ± 0.03
			50 mg	100.86 ± 0.33

ISSN: 2661-801X